The core targets of Hedyotis diffusa in treating cervical cancer mainly included AKT1, VEGFA, TNF, IL6, PTGS2, JUN, IL1B, CASP3, MAPK3, and MMP9. This evidence concerns the gene PTGS2 and cervical carcinoma.